Home › Companies › OrthoPediatrics Corp. › 2025-2026

OrthoPediatrics Corp. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and OrthoPediatrics Corp.’s Form 8-K, filed 2026-06-04 (Item 5.07 on EDGAR). Page generated 02 October 2026.

8Reported items
163Asset managers
1,262Fund votes
2026-06-04Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore OrthoPediatrics Corp. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by OrthoPediatrics Corp.

These tallies are OrthoPediatrics Corp.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-04 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

OrthoPediatrics Corp. — official shareholder meeting results, meeting held 2026-06-04
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: George S. M. Dyer	10,843,747	--	--	8,009,267	1,827,535	Majority: yes
Elect Director: Kelly Fischer	18,535,024	--	--	317,990	1,827,535	Majority: yes
Elect Director: David R. Pelizzon	18,056,773	--	--	796,241	1,827,535	Majority: yes
Elect Director: Harald Ruf	18,077,260	--	--	775,754	1,827,535	Majority: yes

Source: OrthoPediatrics Corp., Form 8-K, filed with the SEC on 2026-06-04 — read the filing on EDGAR.

How asset managers voted at the OrthoPediatrics Corp. 2025-2026 meeting

Each item below shows how the 163 asset managers that disclosed a OrthoPediatrics Corp. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of OrthoPediatrics Corp.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on an advisory basis, the compensation of our executive officers who are named in the compensation disclosures in this proxy statement.

SECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

70% fund support · no official result

FOR 70%AGAINST 30%

The 161 asset managers below cast 70% of the shares they voted on this item FOR (8,571,332 for, 3,690,584 against).

FOR: 8,571,332 (69.9%)AGAINST: 3,690,584 (30.1%)ABSTAIN: 518 (0.0%)NOT VOTED: 34 (0.0%)

Largest asset managers voting on “To approve, on an advisory basis, the compensation of our executive officers who are named in the compensation” at OrthoPediatrics Corp., 2025-2026
Asset manager	For	Against	Vote
BROWN ADVISORY INC	304	1,335,368	Against
Vanguard	987,652	362	For
BlackRock	922,792	2,089	For
BRAIDWELL LP	795,199	0	For
Wellington	640,237	0	For
Soleus Capital Management, L.P.	615,447	0	For
GEODE CAPITAL MANAGEMENT, LLC	432,668	0	For
Fidelity	373,188	0	For
State Street	364,809	3,399	For
Brown Advisory Funds	0	351,132	Against
WASATCH ADVISORS LP	0	328,561	Against
WASATCH FUNDS TRUST	0	326,060	Against
BROWN CAPITAL MANAGEMENT LLC	310,548	0	For
Charles Schwab	278,330	0	For
Goldman Sachs	205,350	35,010	For
Jackson National	231,520	6,509	For
Brown Capital Management Mutual Funds	229,236	0	For
Dimensional	0	225,299	Against
RIVERBRIDGE PARTNERS LLC	219,157	0	For
Principal	0	217,262	Against
Nuveen	163,987	0	For
TIAA	163,638	0	For
Victory Capital	151,267	3,860	For
Prosight Management, LP	148,309	0	For
Triodos Investment Management BV	147,000	0	For

Showing the 25 largest of 161 asset managers. See all 161 in the interactive database.

2. To elect four (4) directors, each to serve until the 2029 annual meeting of our stockholders: David R. Pelizzon

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 18,056,773WITHHELD: 796,241

OrthoPediatrics Corp.’s own tally for this item (“Elect Director: David R. Pelizzon”): 18,056,773 for, 796,241 withheld, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 25,684,994 outstanding shares: 70% for, 3% withheld (73% of the company cast a for/withheld vote).

The 52 asset managers below cast 100% of the shares they voted on this item FOR (4,372,597 for, 0 against).

FOR 96%

FOR: 4,372,597 (95.7%)ABSTAIN: 194,708 (4.3%)

Largest asset managers voting on “To elect four (4) directors, each to serve until the 2029 annual meeting of our stockholders: David R. Pelizzo” at OrthoPediatrics Corp., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	857,677	1,477	For
BlackRock	436,255	0	For
Fidelity	372,074	0	For
Brown Advisory Funds	351,132	0	For
WASATCH FUNDS TRUST	326,060	0	For
Jackson National	231,520	6,509	For
Brown Capital Management Mutual Funds	229,236	0	For
Principal	217,262	0	For
Dimensional	0	170,418	Abstain
TIAA	163,638	0	For
Goldman Sachs	160,907	0	For
Victory Capital	153,197	0	For
MoA Funds Corp	143,463	0	For
Charles Schwab	139,161	0	For
Harbor Funds II	134,992	0	For
Grandeur Peak Global Trust	84,051	0	For
NYLIM VP FUNDS TRUST	79,187	0	For
State Street	47,533	104	For
American Century	40,632	0	For
Equitable	28,815	9,030	For
QUANTITATIVE MASTER SERIES LLC	28,227	0	For
BUFFALO FUNDS	25,717	0	For
PACE SELECT ADVISORS TRUST	15,684	0	For
Nationwide	13,520	0	For
Lincoln Financial	11,405	1,484	For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

3. To elect four (4) directors, each to serve until the 2029 annual meeting of our stockholders: George S. M. Dyer, MD

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

58% Majority: yes · of votes cast

FOR 58%WITHHELD 42%

FOR: 10,843,747WITHHELD: 8,009,267

OrthoPediatrics Corp.’s own tally for this item (“Elect Director: George S. M. Dyer”): 10,843,747 for, 8,009,267 withheld, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 25,684,994 outstanding shares: 42% for, 31% withheld (73% of the company cast a for/withheld vote).

The 52 asset managers below cast 100% of the shares they voted on this item FOR (522,559 for, 0 against).

11%ABSTAIN 89%

FOR: 522,559 (11.4%)ABSTAIN: 4,044,746 (88.6%)

Largest asset managers voting on “To elect four (4) directors, each to serve until the 2029 annual meeting of our stockholders: George S. M. Dye” at OrthoPediatrics Corp., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	1,183	857,970	Abstain
BlackRock	0	436,255	Abstain
Fidelity	0	372,074	Abstain
Brown Advisory Funds	0	351,132	Abstain
WASATCH FUNDS TRUST	0	326,060	Abstain
Jackson National	231,520	6,509	For
Brown Capital Management Mutual Funds	0	229,236	Abstain
Principal	0	217,262	Abstain
Dimensional	0	170,418	Abstain
TIAA	0	163,638	Abstain
Goldman Sachs	0	160,907	Abstain
Victory Capital	151,267	1,930	For
MoA Funds Corp	0	143,463	Abstain
Charles Schwab	0	139,161	Abstain
Harbor Funds II	0	134,992	Abstain
Grandeur Peak Global Trust	84,051	0	For
NYLIM VP FUNDS TRUST	0	79,187	Abstain
State Street	42	47,595	Abstain
American Century	0	40,632	Abstain
Equitable	0	37,845	Abstain
QUANTITATIVE MASTER SERIES LLC	0	28,227	Abstain
BUFFALO FUNDS	25,717	0	For
PACE SELECT ADVISORS TRUST	15,684	0	For
Nationwide	0	13,520	Abstain
Lincoln Financial	0	12,889	Abstain

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

4. To elect four (4) directors, each to serve until the 2029 annual meeting of our stockholders: Harald Ruf

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 18,077,260WITHHELD: 775,754

OrthoPediatrics Corp.’s own tally for this item (“Elect Director: Harald Ruf”): 18,077,260 for, 775,754 withheld, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 25,684,994 outstanding shares: 70% for, 3% withheld (73% of the company cast a for/withheld vote).

The 52 asset managers below cast 100% of the shares they voted on this item FOR (4,372,603 for, 0 against).

FOR 96%

FOR: 4,372,603 (95.7%)ABSTAIN: 194,702 (4.3%)

Largest asset managers voting on “To elect four (4) directors, each to serve until the 2029 annual meeting of our stockholders: Harald Ruf” at OrthoPediatrics Corp., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	857,677	1,477	For
BlackRock	436,255	0	For
Fidelity	372,074	0	For
Brown Advisory Funds	351,132	0	For
WASATCH FUNDS TRUST	326,060	0	For
Jackson National	231,520	6,509	For
Brown Capital Management Mutual Funds	229,236	0	For
Principal	217,262	0	For
Dimensional	0	170,418	Abstain
TIAA	163,638	0	For
Goldman Sachs	160,907	0	For
Victory Capital	153,197	0	For
MoA Funds Corp	143,463	0	For
Charles Schwab	139,161	0	For
Harbor Funds II	134,992	0	For
Grandeur Peak Global Trust	84,051	0	For
NYLIM VP FUNDS TRUST	79,187	0	For
State Street	47,539	98	For
American Century	40,632	0	For
Equitable	28,815	9,030	For
QUANTITATIVE MASTER SERIES LLC	28,227	0	For
BUFFALO FUNDS	25,717	0	For
PACE SELECT ADVISORS TRUST	15,684	0	For
Nationwide	13,520	0	For
Lincoln Financial	11,405	1,484	For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

5. To elect four (4) directors, each to serve until the 2029 annual meeting of our stockholders: Kelly Fischer

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 18,535,024WITHHELD: 317,990

OrthoPediatrics Corp.’s own tally for this item (“Elect Director: Kelly Fischer”): 18,535,024 for, 317,990 withheld, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 25,684,994 outstanding shares: 72% for, 1% withheld (73% of the company cast a for/withheld vote).

The 52 asset managers below cast 100% of the shares they voted on this item FOR (4,430,648 for, 0 against).

FOR 97%

FOR: 4,430,648 (97.0%)ABSTAIN: 136,657 (3.0%)

Largest asset managers voting on “To elect four (4) directors, each to serve until the 2029 annual meeting of our stockholders: Kelly Fischer” at OrthoPediatrics Corp., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	857,678	1,476	For
BlackRock	436,255	0	For
Fidelity	372,074	0	For
Brown Advisory Funds	351,132	0	For
WASATCH FUNDS TRUST	326,060	0	For
Jackson National	238,029	0	For
Brown Capital Management Mutual Funds	229,236	0	For
Principal	217,262	0	For
Dimensional	170,418	0	For
TIAA	163,638	0	For
Goldman Sachs	160,907	0	For
Victory Capital	153,197	0	For
MoA Funds Corp	143,463	0	For
Charles Schwab	139,161	0	For
Harbor Funds II	0	134,992	Abstain
Grandeur Peak Global Trust	84,051	0	For
NYLIM VP FUNDS TRUST	79,187	0	For
State Street	47,539	98	For
American Century	40,632	0	For
Equitable	37,845	0	For
QUANTITATIVE MASTER SERIES LLC	28,227	0	For
BUFFALO FUNDS	25,717	0	For
PACE SELECT ADVISORS TRUST	15,684	0	For
Nationwide	13,520	0	For
Lincoln Financial	12,889	0	For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

6. TO APPROVE AN AMENDMENT TO THE 2024 INCENTIVE AWARD PLAN.

COMPENSATION

96% fund support · no official result

FOR 96%

The 52 asset managers below cast 96% of the shares they voted on this item FOR (4,402,095 for, 165,210 against).

FOR: 4,402,095 (96.4%)AGAINST: 165,210 (3.6%)

Largest asset managers voting on “TO APPROVE AN AMENDMENT TO THE 2024 INCENTIVE AWARD PLAN.” at OrthoPediatrics Corp., 2025-2026
Asset manager	For	Against	Vote
Vanguard	859,153	1	For
BlackRock	436,255	0	For
Fidelity	372,074	0	For
Brown Advisory Funds	351,132	0	For
WASATCH FUNDS TRUST	326,060	0	For
Jackson National	238,029	0	For
Brown Capital Management Mutual Funds	229,236	0	For
Principal	217,262	0	For
Dimensional	170,418	0	For
TIAA	0	163,638	Against
Goldman Sachs	160,907	0	For
Victory Capital	153,197	0	For
MoA Funds Corp	143,463	0	For
Charles Schwab	139,161	0	For
Harbor Funds II	134,992	0	For
Grandeur Peak Global Trust	84,051	0	For
NYLIM VP FUNDS TRUST	79,187	0	For
State Street	47,631	6	For
American Century	40,632	0	For
Equitable	37,845	0	For
QUANTITATIVE MASTER SERIES LLC	28,227	0	For
BUFFALO FUNDS	25,717	0	For
PACE SELECT ADVISORS TRUST	15,684	0	For
Nationwide	13,520	0	For
Lincoln Financial	12,889	0	For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

7. TO APPROVE, ON AN ADVISORY BASIS, THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2026.

AUDIT-RELATED

99.9% fund support · no official result

FOR 99.9%

The 52 asset managers below cast 99.9% of the shares they voted on this item FOR (4,553,052 for, 6 against).

FOR: 4,553,052 (100.0%)AGAINST: 6 (0.0%)

Largest asset managers voting on “TO APPROVE, ON AN ADVISORY BASIS, THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLI” at OrthoPediatrics Corp., 2025-2026
Asset manager	For	Against	Vote
Vanguard	859,154	0	For
BlackRock	436,255	0	For
Fidelity	372,074	0	For
Brown Advisory Funds	351,132	0	For
WASATCH FUNDS TRUST	326,060	0	For
Jackson National	238,029	0	For
Brown Capital Management Mutual Funds	229,236	0	For
Principal	217,262	0	For
Dimensional	170,418	0	For
TIAA	163,638	0	For
Goldman Sachs	160,907	0	For
Victory Capital	153,197	0	For
MoA Funds Corp	143,463	0	For
Charles Schwab	139,161	0	For
Harbor Funds II	134,992	0	For
NYLIM VP FUNDS TRUST	79,187	0	For
Grandeur Peak Global Trust	69,804	0	For
State Street	47,631	6	For
American Century	40,632	0	For
Equitable	37,845	0	For
QUANTITATIVE MASTER SERIES LLC	28,227	0	For
BUFFALO FUNDS	25,717	0	For
PACE SELECT ADVISORS TRUST	15,684	0	For
Nationwide	13,520	0	For
Lincoln Financial	12,889	0	For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

8. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (854,261 for, 0 against).

FOR: 854,261 (100.0%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at OrthoPediatrics Corp., 2025-2026
Asset manager	For	Against	Abstain	Withheld	Vote
Granahan Investment Management, LLC	826,186	0	0	0	For
FORUM FUNDS II	28,075	0	0	0	For

Largest OrthoPediatrics Corp. shareholders voting in 2025-2026

Ranked by the number of OrthoPediatrics Corp. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 25,684,994 shares outstanding at the time of that meeting.

Top OrthoPediatrics Corp. shareholders by shares voted, 2025-2026
#	Asset manager	% of shares outstanding
1	BROWN ADVISORY INC	5.20%
2	Vanguard	3.85%
3	BlackRock	3.60%
4	BRAIDWELL LP	3.10%
5	Wellington	2.49%
6	Soleus Capital Management, L.P.	2.40%
7	GEODE CAPITAL MANAGEMENT, LLC	1.68%
8	Fidelity	1.45%
9	State Street	1.43%
10	Brown Advisory Funds	1.37%

Reported OrthoPediatrics Corp. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

OrthoPediatrics Corp. beneficial owners on record for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
David R. Pelizzon	27.00%	DEF14A
Squadron Capital LLC	26.87%	DEF14A
Brown Advisory Incorporated	6.31%	DEF14A
Millennium Management	4.82%	13F
BlackRock	4.57%	13F
Morgan Stanley	4.35%	13F
Vanguard Group	3.78%	13F
Wellington Management	3.46%	13F
Integrated Core Strategies (US) LLC	3.16%	13G
Dimensional Fund Advisors	2.13%	13F

Percentages above are of 25,684,994 shares outstanding, as reported by OrthoPediatrics Corp. on its Form 10-Q dated 2026-04-29 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from OrthoPediatrics Corp.’s 10-Q dated 2026-04-29. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At OrthoPediatrics Corp.'s shareholder meeting held 2026-06-04, in the 2025-2026 proxy season, 163 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,262 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. OrthoPediatrics Corp.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, on an advisory basis, the compensation of our executive officers who are named in… — the reporting funds cast 70% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

OrthoPediatrics Corp. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).